Modulation of soluble Adenylyl Cyclase (sAC) as a Method of Altering Melanocyte Pigmentation

Principal Investigator: 

Jonathan Zippin, Associate Professor of Dermatology

Background & Unmet Need

  • Melanin is a natural pigment responsible for giving color and protecting the skin and eyes from excess ultraviolet (UV) radiation
  • Oculocutaneous albinism (OCA) is a group of pigment diseases defined by a loss of pigment in the eyes, skin, and hair
  • Loss of pigment has significant psychosocial effects and can lead to vision defects and skin cancer
  • Melanin is also implicated in the brain, where neuromelanin is produced using similar mechanisms as the skin
  • Patients with Parkinson's only have about 50% of the normal amount of neuromelanin in the substantia nigra, and increased levels of neuromelanin could potentially be used to treat these patients
  • Unmet Need: Methods of modulating melanin production and pigmentation for treatment of melanin-related diseases

Technology Overview

  • The Technology: Methods to modulate melanin production via soluble Adenylyl Cyclase (sAC) by altering melanosome pH
  • The Discovery: The inventor has discovered that sAC, a non-canonical source of cAMP, acts as a pH sensor in a second cAMP-signaling pathway which regulates pigmentation
  • Through this pathway, the loss or inhibition of sAC-specific cAMP increases melanin production
  • As the most common forms of OCA are due to improper melanosome pH levels, treatment with sAC inhibitors can rescue abnormal pH and pigmentation
  • PoC Data: Topical treatment of mice with sAC inhibitors has been shown to increase pigmentation in the skin, eyes and hair
  • Intraperitoneal injection of sAC inhibitors restored melanosomal pH to normal levels and increased pigmentation of eyes in a mouse model of OCA type 2

Technology Applications

  • Treatment of patients with albinism including oculocutaneous albinism, a group of rare diseases
  • Reduction of risk for skin cancer by increasing pigmentation
  • Treatment of Parkinson’s Disease via increasing levels of neuromelanin
  • Cosmetic applications for the darkening of skin or hair, such as self-tanning lotions or hair coloring

Technology Advantages

  • sAC-specific cAMP acts in a distinct cAMP signaling cascade to induce melanin induction, so sAc inhibitors represent a new class of pigment regulators
  • sAC inhibitors can be applied topically for area-specific modulation
Mice showing different pigmentations

Figure 1: Top: Loss of sAc via genetic knockout in mice increases pigmentation in the hair Bottom: Topical application of sAC inhibitors LRE1 or KH7 increased melanin and pigmentation in the epidermis.

Intellectual Property

Patents

  • US Application Filed US20190256856: "Methods of modulating melanosome ph and melanin level in cells"

Cornell Reference

  • 7464

Contact Information

Brian Kelly, Ph.D.

For additional information please contact

Brian Kelly
Director, Business Development and Licensing
Phone: (646) 962-7041
Email: bjk44@cornell.edu